絞り込み

17092

広告

「"Glorieux FH "[Author]」の検索結果

282件中 121件~140件表示    検索結果をPubMedで見る PubMedで見る

Single-dose pharmacokinetics and tolerability of alendronate 35- and 70-milligram tablets in children and adolescents with osteogenesis imperfecta type I.

Bone mineralization and growth are enhanced in preterm infants fed an isocaloric, nutrient-enriched preterm formula through term.

Three children with lower limb fractures and a mineralization defect: a novel bone fragility disorder?

Functional analysis of upper limb deformities in osteogenesis imperfecta.

Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate.

Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases.

Osteopathia striata with cranial sclerosis: clinical, radiological, and bone histological findings in an adolescent girl.

Rescue of the phenotype of CYP27B1 (1alpha-hydroxylase)-deficient mice.

Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta.

Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna.

Osteogenesis imperfecta.

Effect of gene dose and parental origin on bone histomorphometry in X-linked Hyp mice.

Bisphosphonates in children with bone diseases.

Genetic changes in the RNA components of RNase MRP and RNase P in Schmid metaphyseal chondrodysplasia.

Osteogenesis imperfecta--clinical and molecular diversity.

Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone.

Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta.

Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.

Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1).

  1. 3
  2. 4
  3. 5
  4. 6
  5. 7
  6. 8
  7. 9
Sort by
※並べ替えは表示に時間がかかります